New England Research & Management, Inc. Moderna, Inc. Transaction History

New England Research & Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	SELL	$126.46 - $235.05 $268,474 - $499,011	-2,123 Closed	0 $0
Q4 2021 Jan 05, 2022	SELL	$225.82 - $368.51 $96,650 - $157,722	-428 Reduced 16.78%	2,123 $539,000
Q3 2021 Oct 08, 2021	SELL	$221.9 - $484.47 $33,063 - $72,186	-149 Reduced 5.52%	2,551 $982,000
Q2 2021 Jul 15, 2021	BUY	$129.91 - $234.98 $149,396 - $270,227	1,150 Added 74.19%	2,700 $634,000
Q1 2021 Apr 16, 2021	SELL	$109.18 - $185.98 $447,638 - $762,518	-4,100 Reduced 72.57%	1,550 $203,000

Q4 2020 Jan 07, 2021	BUY	$65.74 - $169.86 $371,431 - $959,709	5,650 New	5,650 $590,000

1,037

245M

12.1M

9.36M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $45.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

Stay updated on New England Research & Management, Inc. with notifications on news.